Peripheral arterial disease as a predictor of outcome after renal transplantation. 1998

H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
Department of Surgery, Helsinki University Central Hospital, Finland.

Our aim was to assess the prevalence of symptomatic and asymptomatic peripheral occlusive arterial disease (POAD) in 129 consecutive diabetic (n = 34) and nondiabetic (n = 95) patients undergoing renal transplantation. The association of pre-existent POAD and complaints of claudication, lower limb amputations, and graft and patient survival were evaluated during a 5-year follow up. A questionnaire on walking capacity, ankle/brachial (ABI) and toe/brachial (TBI) pressure indices as well as the pulse volume recording (PVR) at the ankle were used to assess resting haemodynamics and the presence of POAD 4 days after the transplantation. Unquestionable ischaemia was encountered in 5 (4%) patients all with a history of intermittent claudication and an ABI equal or below 0.77. While using assessment methods not affected by vessel calcification, i.e. toe pressures and PVR damping, a many-fold frequency of arterial disease was observed when compared to previous studies. TBI below 0.65 was found in 11 of diabetic (32%) and in 15 of the others (16%), and a PVR amplitude below 5 min in 28 of diabetics (82%) and in 34 of non-diabetics (36%). During the 5-year follow up, abnormal TBI and PVR values and diabetes at the time of transplantation were the greatest risk factors for proximal foot amputations. The low TBI levels also indicated a shortened patient survival. However, transplant function was not affected by the presence of abnormal haemodynamic indices at the time of transplantation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001157 Arterial Occlusive Diseases Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. Arterial Obstructive Diseases,Arterial Occlusion,Arterial Obstructive Disease,Arterial Occlusions,Arterial Occlusive Disease,Disease, Arterial Obstructive,Disease, Arterial Occlusive,Obstructive Disease, Arterial,Occlusion, Arterial,Occlusive Disease, Arterial
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
April 2000, Transplantation,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
November 2023, Vascular,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
July 2006, Journal of the American Society of Nephrology : JASN,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
January 2002, Journal of hypertension,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
April 2014, The American journal of the medical sciences,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
January 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
November 2011, Interactive cardiovascular and thoracic surgery,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
February 2019, Herz,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
January 2013, Global cardiology science & practice,
H Mäkisalo, and M Lepäntalo, and L Halme, and T Lund, and S Peltonen, and K Salmela, and J Ahonen
January 1999, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!